US Stock MarketDetailed Quotes

SXTP 60 Degrees Pharmaceuticals

Watchlist
  • 1.410
  • -0.240-14.55%
Close Dec 13 16:00 ET
  • 1.400
  • -0.010-0.71%
Post 19:50 ET
3.24MMarket Cap-0.44P/E (TTM)

60 Degrees Pharmaceuticals Key Stats

60 Degrees Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 300.000K--
--2024/Q4-- / 234.000K--
--2024/Q3135.290K / 242.000K--
--2024/Q2124.970K / 211.500K--
--2024/Q1116.460K / 150.000K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 300.000K--
--2024/Q4-- / 234.000K--
--2024/Q3135.290K / 242.000K--
--2024/Q2124.970K / 211.500K--
--2024/Q1116.460K / 150.000K--

Unlock Free Earnings Estimates

60 Degrees Pharmaceuticals Earnings Reports

Read more

Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Dec 3, 2024

Buy

  • Buy

    50.00%
  • Hold

    50.00%
  • Sell

    0.00%

Price Target

No Data